Concurrent BRAFV600E and BRCA mutations in microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Prevalence and case series of mCRC (pts) with prolonged overall survival (OS)

Authors :: Ethan Sokol
Raymond C. Wadlow
Timothy L. Cannon
Halla Nimeiri
Jamie Randall
John F. Deeken
Sonja Alexander
Daniel Barnett
Danny Rayes
Kimberly McGregor
Source :: Journal of Clinical Oncology. 39:3561-3561
Publication Year :: 2021
Publisher :: American Society of Clinical Oncology (ASCO), 2021.
Abstract: 3561 Background: BRAF V600E+, MSS mCRC patients comprise up to 10% of advanced CRC. They have a poor prognosis with median survivals typically

Subjects :: Oncology
Cancer Research
Series (stratigraphy)
medicine.medical_specialty
Poor prognosis
endocrine system diseases
business.industry
Colorectal cancer
medicine.disease
digestive system diseases
BRAF V600E
Microsatellite Stable
Internal medicine
Overall survival
Medicine
skin and connective tissue diseases
business
neoplasms

Full Text Access

Tools